Skip to content

In the BioHarmony Drug Report Database

Metreleptin

Myalept, Myalepta (metreleptin) is a protein pharmaceutical. Metreleptin was first approved as Myalept on 2014-02-24. It is used to treat lipodystrophy in the USA. It has been approved in Europe to treat familial partial lipodystrophy.
Trade Name Myalepta
Common Name Metreleptin
Indication familial partial lipodystrophy, lipodystrophy
Drug Class Leptin derivatives
Metreleptin
Get full access now